Effects of the converting enzyme inhibitor trandolapril on short-term variability of blood pressure in essential hypertension. 1991

C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
Pharmacologie Clinique, Fondation de l'Avenir, Paris, France.

Short-term fluctuations in blood pressure and heart rate were analysed in a group of eight males with essential hypertension. Indirect finger blood pressure was measured by a non-invasive device (Finapres). Analogue-to-digital conversion of the blood pressure was used to determine systolic and diastolic blood pressure and heart rate every second. The equidistant sampling allowed a direct spectral analysis using a fast Fourier transformation algorithm. The effect of 7-day administration of the angiotensin converting enzyme inhibitor, transolapril (2 mg/day), was assessed in a double-blind, randomized, placebo-controlled cross-over study. After trandolapril there was a significant reduction in systolic blood pressure levels (-15 mmHg). The reduction in diastolic blood pressure did not reach significance. The standard deviation of systolic and diastolic blood pressure levels were significantly reduced (-20% and -22% for systolic and diastolic respectively). Neither average heart rate nor standard deviations of heart rate time series was affected by the angiotensin converting enzyme inhibitor. Spectral analysis of fluctuation in blood pressure showed a reduction in the variability underlying the standard deviation changes of systolic and diastolic blood pressure. Trandolapril selectively reduced the amplitude of systolic and diastolic oscillations in the 66-129 mHz region, corresponding to Mayer waves. The significant decrease in the 10 s period oscillations of blood pressure after chronic angiotensin converting enzyme blockade with trandolapril could reflect reduced sympathetic outflow to vascular smooth muscle.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
April 1982, Nihon Jinzo Gakkai shi,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
November 1986, Arzneimittel-Forschung,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
November 1988, The American journal of cardiology,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
June 2014, Hypertension research : official journal of the Japanese Society of Hypertension,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
October 1992, The American journal of cardiology,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
July 1988, Journal of cardiovascular pharmacology,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
January 1995, Clinical and experimental hypertension (New York, N.Y. : 1993),
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
February 1982, British journal of clinical pharmacology,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
February 1998, American journal of hypertension,
C Dutrey-Dupagne, and A Girard, and A Ulmann, and J L Elghozi
November 2003, Clinical science (London, England : 1979),
Copied contents to your clipboard!